Fortrea Holdings Inc. (FTRE): EPS (Basic)

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$10.81
Year ended 2025-12-31
$2.092021-12-31: $1.102022-12-31: $2.092023-12-31: -$0.292024-12-31: -$3.672025-12-31: -$10.81-$10.81
2021-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$10.81n/m2026-02-26, From 2025-01-01
2024-12-31-$3.67n/m2026-02-26, From 2024-01-01
2023-12-31-$0.29n/m2026-02-26, From 2023-01-01
2022-12-31$2.09n/c2025-03-03, From 2022-01-01
2021-12-31$1.10n/a2024-03-13, From 2021-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Fortrea Holdings Inc. (FTRE)2025-12-31-$10.81n/m
Natera, Inc. (NTRA)2025-12-31-$1.52n/m
RadNet, Inc. (RDNT)2025-12-31-$0.25n/m
Guardant Health, Inc. (GH)2025-12-31-$3.32n/m
Caris Life Sciences, Inc. (CAI)2025-12-31-$3.22n/m
Quest Diagnostics Inc (DGX)2025-12-31$8.87+14.0%
Labcorp Holdings Inc. (LH)2025-12-31$10.54+18.6%
Veracyte, Inc. (VCYT)2025-12-31$0.84+162.5%
CareDx, Inc. (CDNA)2025-12-31-$0.40n/m

Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗